Resmed Aktie - 0KW4

Professionelle Tools für Privatanleger.

Premium

Current Price

102,85

Gebot

0,00

Fragen

0,00

Volumen

0,00

0,00 Tagesbereich 0,00

102,85 52-Wochen-Bereich 102,85

Marktkapitalisierung

15,109B

Handelsende

102,85

Handelsbeginn

Letzte Trade

18521.71

(O)

Letzter Handelszeitpunkt

22:04:53

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

637

Ausgegebene Aktien

146.907.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

33,50

Gewinn pro Aktie (EPS)

6,95

Erlöse

4,69B

Nettogewinn

1,02B

Sektor

Surgical,med Instr,apparatus

Branche

Surgical,med Instr,apparatus

Website

www.resmed.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Resmed Inc is listed in the Surgical,med Instr,apparatus sector of the Londoner Börse with ticker 0KW4. The last closing price for Resmed was US$102,85. Over the last year, Resmed shares have traded in a share price range of US$ 102,85 to US$ 102,85.

Resmed currently has 146.907.000 shares in issue. The market capitalisation of Resmed is US$15,11 billion. Resmed has a price to earnings ratio (PE ratio) of 33.50.

Vaping Expected to Increase COPD Health and Economic Burden by 2050

Vaping Expected to Increase COPD Health and Economic Burden by 2050 New ResMed-supported research presented at ERS 2024 projects future Chronic...

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia ResMed studies...

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis 36,000 people across 17 markets responded to the company’s fourth annual...

ResMed Adopts New Operating Model to Accelerate Long-term Growth

ResMed Adopts New Operating Model to Accelerate Long-term Growth Justin Leong appointed Chief Product Officer, effective immediately.Katrin...

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software Expands ResMed’s sleep management software...

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP The studies...

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep 81% of respondents...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	102.85	102.85	102.85	408	102.85	DE
4	102.85	102.85	102.85	527	102.85	DE
12	102.85	102.85	102.85	637	102.85	DE
26	102.85	102.85	102.85	907	102.85	DE
52	102.85	102.85	102.85	1283	102.85	DE
156	102.85	102.85	102.85	1707	102.85	DE
260	102.85	102.85	102.85	1119	102.85	DE

0KW4 - Frequently Asked Questions (FAQ)

What is the current Resmed share price?

The current share price of Resmed is US$ 102,85

How many Resmed shares are in issue?

Resmed has 146.907.000 shares in issue

What is the market cap of Resmed?

The market capitalisation of Resmed is USD 15,11B

What is the 1 year trading range for Resmed share price?

Resmed has traded in the range of US$ 102,85 to US$ 102,85 during the past year

What is the PE ratio of Resmed?

The price to earnings ratio of Resmed is 33,5

What is the cash to sales ratio of Resmed?

The cash to sales ratio of Resmed is 7,3

What is the reporting currency for Resmed?

Resmed reports financial results in USD

What is the latest annual turnover for Resmed?

The latest annual turnover of Resmed is USD 4,69B

What is the latest annual profit for Resmed?

The latest annual profit of Resmed is USD 1,02B

What is the registered address of Resmed?

The registered address for Resmed is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Resmed website address?

The website address for Resmed is www.resmed.com

Which industry sector does Resmed operate in?

Resmed operates in the SURGICAL,MED INSTR,APPARATUS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
SCGLSealand Capital Galaxy Limited	3,00p (40,19%)	3,09M
AGRAssura Plc	45,80p (17,44%)	13,05M
ONCOncimmune Holdings Plc	4,50p (12,50%)	52,18k
FXPOFerrexpo Plc	107,00p (11,00%)	1,11M
CPXCap-xx Limited	0,135p (10,20%)	40,51M
SYMESupply@me Capital Plc	0,0052p (-22,96%)	1,47B
PDLPetra Diamonds Limited	24,00p (-17,24%)	208,63k
CARCarclo Plc	20,00p (-13,79%)	179,89k
ALKAlkemy Capital Investments Plc	130,00p (-10,34%)	35,84k
BMVBluebird Mining Ventures Ltd	0,55p (-8,33%)	3,71M
SYMESupply@me Capital Plc	0,0052p (-22,96%)	1,47B
BZTBezant Resources Plc	0,024p (4,35%)	105,99M
BCEBeacon Energy Plc	0,00425p (0,00%)	80M
88E88 Energy Limited	0,09p (9,09%)	50,13M
MSMNMosman Oil And Gas Limited	0,038p (-2,56%)	41,68M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resmed Inc (0KW4)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Resmed Inc

0KW4 Neueste Nachrichten

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed Adopts New Operating Model to Accelerate Long-term Growth

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

ResMed Chief Administrative Officer and Global General Counsel to Retire

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

0KW4 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Resmed Inc (0KW4) Börsenkurse

Resmed Inc (0KW4)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Resmed Inc

0KW4 Neueste Nachrichten

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

ResMed Adopts New Operating Model to Accelerate Long-term Growth

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP

3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer

ResMed Chief Administrative Officer and Global General Counsel to Retire

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

Vaping Expected to Increase COPD Health and Economic Burden by 2050

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

0KW4 - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen